123 related articles for article (PubMed ID: 1511070)
1. Performance characteristics of creatine kinase-MB isoenzyme measured with an immunoenzymometric and an immunoinhibition assay in acute myocardial infarction with and without thrombolytic therapy.
Schiøler V; Thode J; Kjøller E
Eur J Clin Chem Clin Biochem; 1992 Jun; 30(6):357-61. PubMed ID: 1511070
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a commercial immunoenzymometric assay kit for creatine kinase MB isoenzyme determination using monoclonal antibodies.
Panteghini M; Bonora R; Pagani F; Calarco M
J Clin Chem Clin Biochem; 1986 Jan; 24(1):97-102. PubMed ID: 3517221
[TBL] [Abstract][Full Text] [Related]
3. Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin T.
Hetland O; Dickstein K
Scand J Clin Lab Invest; 1996 Dec; 56(8):701-13. PubMed ID: 9034351
[TBL] [Abstract][Full Text] [Related]
4. Optimised function for determining time to peak creatine kinase and creatine kinase-MB as non-invasive reperfusion indicators after thrombolytic therapy in acute myocardial infarction.
Schwerdt H; Ozbek C; Fröhlig G; Schieffer H; Bette L
Cardiovasc Res; 1990 Apr; 24(4):328-34. PubMed ID: 2189569
[TBL] [Abstract][Full Text] [Related]
5. Creatine kinase isoenzymes. Predictive value in the early diagnosis of acute myocardial infarction.
Blomberg DJ; Kimber WD; Burke MD
Am J Med; 1975 Oct; 59(4):464-9. PubMed ID: 1166854
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of acute myocardial infarction with use of a rapid immunochemical assay of creatine kinase MB isoenzyme.
Collins DR; Wright DJ; Rinsler MG; Thomas P; Bhattacharya S; Raftery EB
Clin Chem; 1993 Aug; 39(8):1725-8. PubMed ID: 8353963
[TBL] [Abstract][Full Text] [Related]
7. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction.
Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K
Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123
[TBL] [Abstract][Full Text] [Related]
8. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin.
Mair J; Artner-Dworzak E; Lechleitner P; Morass B; Smidt J; Wagner I; Dienstl F; Puschendorf B
Br Heart J; 1992 Nov; 68(5):462-8. PubMed ID: 1467029
[TBL] [Abstract][Full Text] [Related]
9. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes.
Fesmire FM; Christenson RH; Fody EP; Feintuch TA
Ann Emerg Med; 2004 Jul; 44(1):12-9. PubMed ID: 15226704
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
Selim NA; Hmouda HT
Saudi Med J; 2002 May; 23(5):526-8. PubMed ID: 12070573
[TBL] [Abstract][Full Text] [Related]
11. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.
Okamoto F; Sohmiya K; Ohkaru Y; Kawamura K; Asayama K; Kimura H; Nishimura S; Ishii H; Sunahara N; Tanaka T
Clin Chem Lab Med; 2000 Mar; 38(3):231-8. PubMed ID: 10905760
[TBL] [Abstract][Full Text] [Related]
12. Analytical and clinical evaluation of creatine kinase MB mass assay by IMx: comparison with MB isoenzyme activity and serum myoglobin for early diagnosis of myocardial infarction.
Van Blerk M; Maes V; Huyghens L; Derde MP; Meert R; Gorus FK
Clin Chem; 1992 Dec; 38(12):2380-6. PubMed ID: 1458571
[TBL] [Abstract][Full Text] [Related]
13. Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.
de Groot MJ; Muijtjens AM; Simoons ML; Hermens WT; Glatz JF
Heart; 2001 Mar; 85(3):278-85. PubMed ID: 11179265
[TBL] [Abstract][Full Text] [Related]
14. Mass concentration and activity concentration of creatine kinase isoenzyme MB compared in serum after acute myocardial infarction.
Delanghe JR; De Mol AM; De Buyzere ML; De Scheerder IK; Wieme RJ
Clin Chem; 1990 Jan; 36(1):149-53. PubMed ID: 2404640
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous occurrence of the MB isoenzyme of creatine kinase and macro creatine kinase type 1 in a patient with acute myocardial infarction.
Baum HH; Böhm M; Neumeier D
Int J Cardiol; 1991 May; 31(2):253-5. PubMed ID: 1869339
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a rapid immunoinhibition assay for creatine kinase-MB in suspected myocardial infarction.
Mego DM; Pupa LE; Bailey SR
Mil Med; 1993 Oct; 158(10):651-4. PubMed ID: 8264922
[TBL] [Abstract][Full Text] [Related]
17. Automated creatine kinase-MB estimation by immuno-inhibition: a clinical evaluation.
Delahunty TJ; Foreback CC
Clin Chem; 1980 Apr; 26(5):568-72. PubMed ID: 7020990
[TBL] [Abstract][Full Text] [Related]
18. Time course of serum cardiac enzymes after intracoronary thrombolytic therapy. Creatine kinase, creatine kinase MB isozyme, lactate dehydrogenase, and serum glutamic-oxaloacetic transaminase.
Wei JY; Markis JE; Malagold M; Grossman W
Arch Intern Med; 1985 Sep; 145(9):1596-600. PubMed ID: 4026489
[TBL] [Abstract][Full Text] [Related]
19. Creatine kinase-MB protein mass is a better indicator for the assessment of acute myocardial infarction in the lower range of creatine kinase level.
Seo H; Miyazaki S; Furuno T; Nonogi H; Haze K; Hiramori K
Jpn Heart J; 1993 Nov; 34(6):717-27. PubMed ID: 8164339
[TBL] [Abstract][Full Text] [Related]
20. Systemic short-term fibrinolysis with high-dose streptokinase in acute myocardial infarction: time course of biochemical parameters.
Golf SW; Temme H; Kempf KD; Bleyl H; Brüstle A; Bödeker R; Heinrich D
J Clin Chem Clin Biochem; 1984 Nov; 22(11):723-9. PubMed ID: 6396365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
